<DOC>
	<DOC>NCT03100630</DOC>
	<brief_summary>Randomized study in healthy men and women. Assess the similarity of BMS-986089 when injected into the arm, thigh, or the stomach. Collect data on safety of BMS-986089.</brief_summary>
	<brief_title>Compare Bioavailability of BMS-986089 After Subcutaneous Injection</brief_title>
	<detailed_description />
	<criteria>Healthy participant as determined by no significant deviations in normal medical and surgical history and assessments Body Mass Index 18 kg/m2 to 32 kg/m2 females must be of nonchildbearing potential tattoos or other skin findings on any of the potential injection sites history of chronic muscle pain within 30 days prior to study treatment prior history of IgG1 therapy Other protocol defined inclusion and exclusion criteria apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>